| First Author | Funk LC | Year | 2021 |
| Journal | Mol Cancer Res | Volume | 19 |
| Issue | 1 | Pages | 112-123 |
| PubMed ID | 32948674 | Mgi Jnum | J:303963 |
| Mgi Id | MGI:6515662 | Doi | 10.1158/1541-7786.MCR-20-0488 |
| Citation | Funk LC, et al. (2021) p53 Is Not Required for High CIN to Induce Tumor Suppression. Mol Cancer Res 19(1):112-123 |
| abstractText | Chromosomal instability (CIN) is a hallmark of cancer. While low levels of CIN can be tumor promoting, high levels of CIN cause cell death and tumor suppression. The widely used chemotherapeutic, paclitaxel (Taxol), exerts its anticancer effects by increasing CIN above a maximally tolerated threshold. One significant outstanding question is whether the p53 tumor suppressor is required for the cell death and tumor suppression caused by high CIN. Both p53 loss and reduction of the mitotic kinesin, centromere-associated protein-E, cause low CIN. Combining both genetic insults in the same cell leads to high CIN. Here, we test whether high CIN causes cell death and tumor suppression even in the absence p53. Despite a surprising sex-specific difference in tumor spectrum and latency in p53 heterozygous animals, these studies demonstrate that p53 is not required for high CIN to induce tumor suppression. Pharmacologic induction of high CIN results in equivalent levels of cell death due to loss of essential chromosomes in p53(+/+) and p53(-/-) cells, further demonstrating that high CIN elicits cell death independently of p53 function. IMPLICATIONS: These results provide support for the efficacy of anticancer therapies that induce high CIN, even in tumors that lack functional p53. |
